Clinical jobs provider Medtronic has reported a notable revenue increase for the first quarter of the year and significant success in international sales.
The medical technology company reported revenue of $4 billion (£2.4 billion) in the first three months of 2011, representing an increase of seven per cent year-on-year.
In addition, the organisation enjoyed a successful quarter for international sales, which accounted for 46 per cent of its worldwide revenue.
Omar Ishrak, Medtronic's chairman and chief executive officer, asserted that the results highlighted growth across a number of the firm's businesses, but some challenges did affect the success.
"My top priority is aligning the management team around improving execution and optimising sources of growth," he added.
Earlier this year, the medical technology company announced the first use of Latin American application of its Symplicity Catheter System for renal denervation, which was used to treat a patient with resistant hypertension.